We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CZR
2726
DELISTED
Caesars Entertainment Corporation
CZR
| $195K | ﹤0.01% |
33,076
-1,134
| -3% | -$8.36K |
|
2727
Bassett Furniture
BSET
$171M
| $194K | ﹤0.01% |
6,970
-536
| -7% | -$17.2K |
|
2728
CorVel
CRVL
$3.14B
| $193K | ﹤0.01% |
17,928
-195,360
| -92% | -$2.1M |
|
|
RDEN
2729
DELISTED
ELIZABETH ARDEN INC
RDEN
| $193K | ﹤0.01% |
16,482
-1,121
| -6% | -$12.3K |
|
|
CRC
2730
DELISTED
California Resources Corporation
CRC
| $193K | ﹤0.01% |
7,414
+2,787
| +60% | +$109K |
|
|
GLOG
2731
DELISTED
GASLOG LTD
GLOG
| $192K | ﹤0.01% |
19,947
-335,936
| -94% | -$4.84M |
|
|
BHBK
2732
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $192K | ﹤0.01% |
13,881
-404
| -3% | -$5.8K |
|
2733
Zumiez
ZUMZ
$347M
| $191K | ﹤0.01% |
12,230
-2,126
| -15% | -$48.5K |
|
2734
LGI Homes
LGIH
$1.43B
| $190K | ﹤0.01% |
6,970
-308
| -4% | -$7.27K |
|
2735
LSB Industries
LXU
$822M
| $190K | ﹤0.01% |
16,099
-675
| -4% | -$15K |
|
|
AAMI
2736
Acadian Asset Management
AAMI
$2.94B
| $190K | ﹤0.01% |
12,336
-125
| -1% | -$2.11K |
|
|
XENT
2737
DELISTED
Intersect ENT, Inc
XENT
| $190K | ﹤0.01% |
8,138
+1,119
| +16% | +$30.9K |
|
|
NWBO
2738
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $190K | ﹤0.01% |
30,421
+562
| +2% | +$5.25K |
|
2739
Insteel Industries
IIIN
$631M
| $187K | ﹤0.01% |
11,634
-468
| -4% | -$8.04K |
|
2740
PUT
RH
RH
$3.36B
| $187K | ﹤0.01% |
+2,000
| New | +$197K |
|
|
ACGN
2741
DELISTED
Aceragen Inc
ACGN
| $187K | ﹤0.01% |
412
-19
| -4% | -$8.4K |
|
|
CUNB
2742
DELISTED
CU Bancorp
CUNB
| $187K | ﹤0.01% |
8,332
+278
| +3% | +$6.16K |
|
|
ACAT
2743
DELISTED
Arctic Cat Inc
ACAT
| $187K | ﹤0.01% |
8,423
-168
| -2% | -$4.71K |
|
2744
Mercury Insurance
MCY
$6.07B
| $186K | ﹤0.01% |
3,680
+127
| +4% | +$6.8K |
|
2745
STAAR Surgical
STAA
$1.13B
| $186K | ﹤0.01% |
23,946
-496
| -2% | -$4.08K |
|
2746
Titan International
TWI
$530M
| $186K | ﹤0.01% |
28,107
-2,037
| -7% | -$17.7K |
|
2747
Magnite
MGNI
$2.82B
| $185K | ﹤0.01% |
12,718
-328
| -3% | -$5.01K |
|
2748
Ribbon Communications
RBBN
$361M
| $185K | ﹤0.01% |
32,340
-1,080
| -3% | -$7.28K |
|
|
CNR
2749
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $185K | ﹤0.01% |
17,476
-1,394
| -7% | -$17.1K |
|
|
BV
2750
DELISTED
Bazaarvoice, Inc.
BV
| $185K | ﹤0.01% |
40,986
+883
| +2% | +$4.72K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.